I

Inno-Gene SA
WSE:IGN

Watchlist Manager
Inno-Gene SA
WSE:IGN
Watchlist
Price: 5.04 PLN -0.4% Market Closed
Market Cap: 17.7m PLN
Have any thoughts about
Inno-Gene SA?
Write Note

Inno-Gene SA
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Inno-Gene SA
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
I
Inno-Gene SA
WSE:IGN
Retained Earnings
zł2.2m
CAGR 3-Years
-35%
CAGR 5-Years
N/A
CAGR 10-Years
35%
M
Medicofarma Biotech SA
WSE:MDB
Retained Earnings
-zł3.1m
CAGR 3-Years
-33%
CAGR 5-Years
-114%
CAGR 10-Years
N/A
R
Ryvu Therapeutics SA
WSE:RVU
Retained Earnings
-zł15.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Selvita SA
WSE:SLV
Retained Earnings
zł202.8m
CAGR 3-Years
83%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Inno-Gene SA
Glance View

Market Cap
17.7m PLN
Industry
Life Sciences Tools & Services

Inno Gene SA engages in the management of startup biotechnology companies. The company is headquartered in Poznan, Woj. Wielkopolskie. The company went IPO on 2011-02-08. Inno-Gene SA’s portfolio comprises of Centrum Badan DNA Sp. z o.o., a company that provides services in the field of genetic medical diagnostics, including microbiological diagnosis of infection and the suitability of human congenital diseases using tests performed on DNA microarray technology. On March 22, 2013, the Company established a new subsidiary, Centrum Edukacji Bio-Medycznej Sp. z o.o. On April 11, 2013, the Company established two new indirect subsidiaries, Genomix Sp. z o.o. and Madgenetix Sp. z o.o. In addition, it operates through VitainSillica Sp z o o.

IGN Intrinsic Value
2.03 PLN
Overvaluation 60%
Intrinsic Value
Price
I

See Also

What is Inno-Gene SA's Retained Earnings?
Retained Earnings
2.2m PLN

Based on the financial report for Jun 30, 2024, Inno-Gene SA's Retained Earnings amounts to 2.2m PLN.

What is Inno-Gene SA's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
35%

Over the last year, the Retained Earnings growth was -68%. The average annual Retained Earnings growth rates for Inno-Gene SA have been -35% over the past three years , and 35% over the past ten years .

Back to Top